Ionis Gets FDA Approval for Rare Disease Drug Tryngolza

FDA Approves Tryngolza (olezarsen) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome

drugs.com - 19/Dec 02:12

CARLSBAD, Calif., Dec. 19, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration...

FDA Approves Tryngolza (olezarsen) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome

drugs.com - 19/Dec 02:12

CARLSBAD, Calif., Dec. 19, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration...

ZBH Stock Might Rise Following FDA Nod for OsseoFit

zacks.com - 16/Dec 12:35

Zimmer Biomet's OsseoFit Stemless Shoulder System gets FDA 510(k) approval. The company expects to launch the system in the first quarter of 2025.

Galderma Receives U.S. FDA Approval for Nemluvio (nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis

drugs.com - 15/Dec 22:12

Zug, Switzerland – December 13, 2024 – Galderma today announced that the United States (U.S.) Food and Drug Administration (FDA) has...

FDA Approves Nemluvio for Moderate-to-Severe Atopic Dermatitis

drugs.com - 18/Dec 23:12

WEDNESDAY, Dec. 18, 2024 -- The U.S. Food and Drug Administration has approved Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic...

FDA Approves Nemluvio for Moderate-to-Severe Atopic Dermatitis

drugs.com - 18/Dec 23:12

WEDNESDAY, Dec. 18, 2024 -- The U.S. Food and Drug Administration has approved Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic...

QURE Soars on FDA Alignment for Speedy Approval of Huntington's Drug

zacks.com - 11/Dec 15:02

uniQure stock rallies 110% on reaching alignment with the FDA on key elements of an accelerated approval pathway for AMT-130 to treat Huntington's...

FDA Expands Approval of Vtama to Include Atopic Dermatitis

drugs.com - 19/Dec 22:17

THURSDAY, Dec. 19, 2024 -- The U.S. Food and Drug Administration has approved Vtama (tapinarof) 1 percent cream for an additional indication -- the...

FDA Expands Approval of Vtama to Include Atopic Dermatitis

drugs.com - 19/Dec 22:17

THURSDAY, Dec. 19, 2024 -- The U.S. Food and Drug Administration has approved Vtama (tapinarof) 1 percent cream for an additional indication -- the...

FDA Approved Drug Products Approval List November 2024

pharmabiz.com - 18/Dec 12:18

FDA Approved Drug Products Approval List November 2024

Rubriques :

Ionis Gets FDA Approval for Rare Disease Drug Tryngolza

Articles similaires

FDA Approves Tryngolza (olezarsen) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome

FDA Approves Tryngolza (olezarsen) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome

ZBH Stock Might Rise Following FDA Nod for OsseoFit

Galderma Receives U.S. FDA Approval for Nemluvio (nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis

FDA Approves Nemluvio for Moderate-to-Severe Atopic Dermatitis

FDA Approves Nemluvio for Moderate-to-Severe Atopic Dermatitis

QURE Soars on FDA Alignment for Speedy Approval of Huntington's Drug

FDA Expands Approval of Vtama to Include Atopic Dermatitis

FDA Expands Approval of Vtama to Include Atopic Dermatitis

FDA Approved Drug Products Approval List November 2024

Les derniers communiqués